Charles Flynn
Director/Board Member at SynDevRx, Inc.
Profile
Charles Flynn is currently a Director at SynDevRx, Inc. He obtained his undergraduate degree from Yale University in 2000.
Charles Flynn active positions
Companies | Position | Start |
---|---|---|
SynDevRx, Inc.
SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Director/Board Member | - |
Training of Charles Flynn
Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
SynDevRx, Inc.
SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Charles Flynn